Abstract
Therapy for transplant rejection, autoimmune disease and allergy must target mature lymphocytes that have escaped censoring during their development. FK506 and cyclosporin are immunosuppressants which block three antigen-receptor signalling pathways (NFAT, NFκB and JNK), through inhibition of calcineurin1, and inhibit mature lymphocyte proliferation to antigen2,3,4. Neither drug induces long-lived tolerance in vivo, however, necessitating chronic use with adverse side effects. Physiological mechanisms of peripheral tolerance to self-antigens provide an opportunity to emulate these processes pharmacologically. Here we use gene-expression arrays to provide a molecular explanation for the loss of mitogenic response in peripheral B-cell anergy, one aspect of immunological tolerance5. Self-antigen induces a set of genes that includes negative regulators of signalling and transcription but not genes that promote proliferation. FK506 interferes with calcium-dependent components of the tolerance response and blocks an unexpectedly small fraction of the activation response. Many genes that were not previously connected to self-tolerance are revealed, and our findings provide a molecular fingerprint for the development of improved immunosuppressants that prevent lymphocyte activation without blocking peripheral tolerance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Liu, J. et al. Calcineurin is a common target of cyclophilin–cyclosporin A and FKBP–FK506 complexes. Cell 66, 807–815 (1991).
Kino, T. et al. FK-506, a novel immunosuppressant isolated from a Streptomyces . I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. (Tokyo) 40, 1249– 1255 (1987).
Borel, J. F., Feurer, C., Gubler, H. U. & Stabelin, H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6, 468–475 (1976).
Wicker, L. S. et al. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. Eur. J. Immunol. 20, 2277– 2283 (1990).
Goodnow, C. C. et al. Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 59, 279–368 (1995).
Cooke, M. P. et al. Immunoglobulin signal transduction guides the specificity of B cell–T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179, 425– 438 (1994).
Healy, J. I. et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6, 419–428 (1997).
Healy, J. I., Dolmetsch, R. E., Lewis, R. S. & Goodnow, C. C. Quantitative and qualitative control of antigen receptor signalling in tolerant B lymphocytes. Novartis Found. Symp. 215, 137–144 (1998).
Rathmell, J. C., Fournier, S., Weintraub, B. C., Allison, J. P. & Goodnow, C. C. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells. J. Exp. Med. 188, 651 –659 (1998).
Lipshutz, R. J., Fodor, S. P., Gingeras, T. R. & Lockhart, D. J. High density synthetic oligonucleotide arrays. Nature Genet. 21, 20–24 (1999).
Seyfert, V. L., Sukhatme, V. P. & Monroe, J. G. Differential expression of a zinc finger-encoding gene in response to positive versus negative signaling through receptor immunoglobulin in murine B lymphocytes. Mol. Cell. Biol. 9, 2083–2088 (1989).
Newton, J. S. et al. B cell early response gene expression coupled to B cell receptor, CD40 and interleukin-4 receptor co-stimulation: evidence for a role of the egr-2/krox 20 transcription factor in B cell proliferation. Eur. J. Immunol. 26, 811–816 (1996).
Monroe, J. G. Up-regulation of c-fos expression is a component of the mlg signal transduction mechanism but is not indicative of competence for proliferation. J. Immunol. 140, 1454–1460 (1988).
Huo, L. & Rothstein, T. L. Receptor-specific induction of individual AP-1 components in B lymphocytes. J. Immunol. 154, 3300–3309 (1995).
Grumont, R. J., Rasko, J. E., Strasser, A. & Gerondakis, S. Activation of the mitogen-activated protein kinase pathway induces transcription of the PAC-1 phosphatase gene. Mol. Cell. Biol. 16, 2913–2921 (1996).
Mittelstadt, P. R. & DeFranco, A. L. Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J. Immunol. 150, 4822–4832 (1993).
Hong, J. X., Wilson, G. L., Fox, C. H. & Kehrl, J. H. Isolation and characterization of a novel B cell activation gene. J. Immunol. 150, 3895–3904 (1993).
Solvason, N. et al. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J. Exp. Med. 184, 407–417 (1996).
Pfisterer, P. et al. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol. Cell. Biol. 16, 6160–6168 ( 1996).
Marton, M. J. et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nature Med. 4 , 1293–1301 (1998).
Dolmetsch, R. E., Lewis, R. S., Goodnow, C. C. & Healy, J. I. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386, 855–858 (1997).
Grumont, R. J., Rourke, I. J. & Gerondakis, S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13, 400–411 ( 1999).
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. & Saltiel, A. R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo . J. Biol. Chem. 270, 27489– 27494 (1995).
Iida, S. et al. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nature Genet. 17, 226– 230 (1997).
Mittrucker, H. W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540–543 (1997).
Langdon, W. Y., Harris, A. W., Cory, S. & Adams, J. M. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47, 11–18 ( 1986).
Kuo, C. T., Veselitis, M. L. & Leiden, J. M. LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science 277, 1986–1990 (1997).
Svaren, J. et al. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 16, 3545–3553 ( 1996).
Slemmon, J. R. et al. Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, and neuromodulin. J. Biol. Chem. 271, 15911–15197 (1996).
Adachi, T., Flaswinkel, H., Yakura, H., Reth, M. & Tsubata, T. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J. Immunol. 160, 4662–4665 (1998).
Acknowledgements
R.G., J.I.H., D.H.M. and C.C.G. gratefully acknowledge the advice and support of M. M. Davis, and advice from J. Cyster, G. Ghandour, D. Lockhart and D. Venter. This work was supported in part by grants from the NIH and the Human Frontiers Science Program.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Information
Supplementary Information (PDF 363 kb)
Rights and permissions
About this article
Cite this article
Glynne, R., Akkaraju, S., Healy, J. et al. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature 403, 672–676 (2000). https://doi.org/10.1038/35001102
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35001102
This article is cited by
-
Topical tacrolimus in anterior segment inflammatory disorders
Eye and Vision (2017)
-
IgD attenuates the IgM-induced anergy response in transitional and mature B cells
Nature Communications (2016)
-
The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry
Nature Immunology (2012)
-
Endogenous antigen tunes the responsiveness of naive B cells but not T cells
Nature (2012)
-
Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from intracellular compartments
Nature Immunology (2011)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.